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Abstract
Background:  An increase in the number of overweight and obese subjects in the general
population has been observed.
The aim of this study was to determine the prevalence of overweight and obese subjects in the
general population and its association with undiagnosed pathologies, such as diabetes mellitus [DM]
and hypertension [HT], by taking age, gender and place of residence [rural or urban] into account.
Findings: A cross-sectional population-based survey was conducted in Castellón, East Spain in
2005–2006. The sample included 2,062 participants aged 18–94 years. Weight, height, blood
pressure and glycaemia values were recorded, and information about gender, age and place of
residence was obtained. Overweight, obesity, and undiagnosed HT and DM prevalences were
calculated. Multiple regression analyses were done to assess the association of overweight/obesity
with undiagnosed HT and DM by adjusting for age, gender and place of residence.
The overall overweight, obesity, and undiagnosed HT and DM prevalences were 39.9% [95%
CI:37.3–42.0], 25.9% [95% CI:24.0–27.9], 9.0% [95% CI:7.8–10.4] and 12.6% [95% CI:11.2–14.1],
respectively. We identified various independent risk factors; those relating to overweight were
increasing age, male gender and rural residential area, while that relating to obesity was increasing
age. Compared to normal weight adults, the Relative Prevalence Ratio (RPR) for subjects who were
overweight and had HT was 2.00 [95% CI:1.21–3.32]; that for obesity and HT was 1.91 [95%
CI:1.48–2.46], and it was 1.50 [95% CI:1.25–1.81] for obesity and DM.
Conclusion: Overweight and obesity prevalences, and their association with undiagnosed DM and
HT, are high in our study population.
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Background
In the last two decades, the prevalence of overweight and
obesity has increased worldwide [1], mainly in the adult
population [2], and in both developed and developing
countries [3].
In Europe, obesity prevalence rates have increased by 30%
since the mid 80's [4], and are presently between 4.0–
28.3% in men, and 6.2–36.5% in women. Diverse find-
ings have been noted among various European countries:
Eastern and Mediterranean countries have the highest
prevalence, and Western and Northern countries have the
lowest [4].
It is suspected that Spain has the highest prevalences in
the European Union for both genders [4], and a geograph-
ical prevalence distribution also exists within Spain, this
being higher in Southeast and Northern Spain [5,6]. A
growing trend, which is in line with the rest of the world,
is also noted and will imply increased associated mortality
and, indeed, currently claims some 28,000 deaths a year
[6,7].
This increased prevalence of obesity has also been associ-
ated with the increased risk of numerous comorbidities
like hypertension [HT] [8-10] and diabetes mellitus [DM]
[10,11]. A linear relationship between adiposity and HT
has been noted [12]. Diabetes mellitus is a world public
health priority, not only because its prevalence has
sharply increased in the last decade [10], but also because
of the high morbidity and mortality that it causes [13,14].
This study aims to determine the overweight and obesity
prevalences in the general adult population and their
association with undiagnosed pathologies [DM and HT]
by taking age, gender and area of residence [rural or
urban] into account.
Methods
Study design
A cross-sectional study was done in a general population
of Castellón, Eastern Spain in 2005–2006.
The study population
The study population included subjects aged 18 years or
older and who were undiagnosed with DM and HT.
In the study area [Castellón], there are 3 Health Districts
with a population of 431,093 subjects aged 18 years or
older [15].
Of this population we selected 8,400 subjects by a ran-
dom, stratified, multi-stage sampling technique in which
the first-stage units were Primary Health Care Centres.
Those with diagnosed HT or/and DM were excluded
[3,503, 41.7%].
The other 4,898 subjects [undiagnosed of HT and DM]
were located by telephone and invited to participate in the
study. This sample size allows us an accuracy of 99.0% for
an expected obesity prevalence of 15.5% [3]. The subjects
who accepted invitations to participate were seen in a cen-
tre of biological analysis.
The final sample included 2,062 adults [response rate,
42.1%], 643 men [31.18%] and 1419 women [68.82%].
This sample size allows us to an accuracy of 98.5% for an
expected obesity prevalence of 15.5% [3].
Participants' ages ranged from 18 to 94 years. The mean
age of men and women was 58.00 ± 14.73 and 54.83 ±
14.52 respectively. Written consent to participate in the
study was obtained from all the participants.
Measurements
Specially trained professionals [clinical specialist pharma-
cists] conducted an anthropometric study with the partic-
ipants. This study recorded weight [kg], height, and
calculated body mass index [BMI] [kg/m2]. Those individ-
uals whose BMI was between 25.0 and 29.9 kg/m2 were
considered overweight, while those with a BMI equal or
over 30 kg/m2 were classified as obese [7].
The participants' blood pressure was consecutively taken
three times and the arithmetic mean was calculated. Diag-
nosing HT was conducted by following the World Health
Organization's [WHO] criteria [HT: subjects with systolic
pressure > 140 mmHg, and diastolic pressure > 90
mmHg] [8].
Capillary glycaemia [CG] was also determined in all the
participants. Only in those participants whose CG value
exceeded 106 mg/dl [if he/she had not eaten breakfast] or
140 mg/dl [if he/she had eaten breakfast], was venous gly-
caemia [VG] also dertmined by taking blood samples
[before they ate breakfast in all the cases]. Diagnosing DM
was conducted based on VG by following the American
Diabetes Association criteria [DM: subjects with a VG
value before eating breakfast of > 126 g/dl] [16].
Information about the participants' age, gender, and place
of residence was obtained through interviews. We distin-
guished between places of residence as follows: rural areas
with < 10,000 inhabitants; urban: areas with ≥ 10,000
inhabitants.
Statistical analysis
Overweight, obesity and undiagnosed HT and DM [who
were not on HT/DM treatment and whose blood pressure/
VG exceeded the limits stated] prevalences were calculated
with their corresponding confidence intervals [CI 95%].
Comparisons were done with the Chi-square test [p ≤
0.05].BMC Research Notes 2009, 2:151 http://www.biomedcentral.com/1756-0500/2/151
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Given the sample's lack of representativeness, prevalences
were estimated in the adult population of the province of
Castellón by the direct standardisation procedure for sam-
ples in terms of age and gender [17] by taking the 2008
population census as a reference [15].
In order to determine the relationship of being over-
weight/obese with age, gender, place of residence and
having undiagnosed DM/HT, a multiple regression logis-
tic analysis was done by calculating the relative prevalence
ratios [RPR], which was adjusted for age, gender and place
of residence, as well as their corresponding CI 95%. Statis-
tical analyses were done with the SPSS v.15 software.
Results
Overweight and obesity prevalences
The total overweight and obesity prevalences obtained
were 39.9% [95% CI:37.7–42.0] and 25.9% [95%
CI:24.0–27.9], respectively. By extrapolating to the adult
population of Castellón, which had been adjusted for age
and gender, the estimated overweight and obesity preva-
lences were 38.0% [95% CI:37.8–38.2] and 16.7% [95%
CI:16.6–16.9] [Table 1].
Undiagnosed HT Prevalence
Of all the participants, 186 had undiagnosed HT with a
prevalence of 9.0% [95% CI:7.8–10.4]. By extrapolating
to the adult population of Castellón, the estimated HT
prevalence was 5.5% [95% CI:5.4–5.6] [Table 2].
Undiagnosed DM Prevalence
Of all the participants, 260 had DM with a prevalence of
12.6% [95% CI:11.2–14.1]. By extrapolating to the adult
population of Castellón, the estimated DM prevalence
was 7.3% [95% CI:7.2–7.4] [Table 2].
Gender, age and place of residence
As Table 1 shows, we saw a trend of the overweight prev-
alence increasing with age, which went from 27.4% in the
34 year-old and younger age group to 44.2% in the 45–54
year-old age group [p-value < 0.001].
Table 1: Age and gender stratified overweight and obesity prevalences among 2062 residents of Castellón.
Men Women Total
Overweight Obesity Overweight Obesity Overweight Obesity
Age Group No
% (95%CI)
No
% (95%CI)
No
% (95%CI)
No
% (95%CI)
No
% (95%CI)
No
% (95%CI)
≤ 34 15
39.5 (25.0–55.5)
3
7.9 (2.0–20.0)
19
22.0 (14.3–31.8)
4
4.6 (1.5–10.8)
34
27.4 (20.1–35.8)
7
5.7 (2.5–10.8)
35–44 45
51.2 (40.7–61.5)
16
18.2 (11.1–27.3)
73
23.8 (19.3–28.8)
42
13.7 (10.2–17.9)
118
29.9 (25.5–34.5)
58
14.7 (11.4–18.4)
45–54 82
63.0 (54.5–71.0)
22
16.9 (11.2–24.1)
122
36.5 (3.5–41.8)
78
23.3 (19.0–28.1)
205
44.2 (39.7–48.7)
100
21.5 (18.0–25.5)
55–64 63
46.6 (38.4–55.1)
43
31.8 (24.4–40.1)
112
40.6 (34.9–46.5)
100
36.2 (30.7–42.0)
175
42.6 (37.9–47.4)
143
34.8 (30.3–39.5)
≥ 65 119
47.2 (41.1–53.4)
69
27.4 (22.1–33.1)
170
40.9 (36.2–45.6)
157
37.7 (33.2–42.5)
290
43.4 (39.7–47.2)
226
33.9 (30.3–37.5)
Total 324
50.4 (46.5–54.2)
153
23.8 (20.6–27.3)
496
34.9 (32.5–37.5)
381
26.8 (24.6–29.2)
822
39.9 (37.7–42.0)
534
25.9 (24.0–27.9)
Age and gender-adjusted† % 
(95%CI)
46.8 (46.6–47.1) 16.0 (15.8–16.2) 29.3 (29.1–29.6) 17.4 (17.3–17.6) 38.0 (37.8–38.2) 16.7 (16.6–16.9)
Overweight: Subjects with BMI = 25–29.9 Kg/m2
Obesity: Subjects with BMI ≥ 30 Kg/m2
No = Number of overweight or obese adults
† Adjusted for the age and gender distribution of the population of CastellónBMC Research Notes 2009, 2:151 http://www.biomedcentral.com/1756-0500/2/151
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Regarding the obesity prevalence, we observed that it
increased with age, and went from 5.7% in the 34 year-old
and younger age group to 34.8% in the 55–64 year-old
age group [p-value < 0.001].
Table 3 shows an RPR of overweight in subjects in the 65
and older age group of 4.42 [95% CI:2.78–7.01] com-
pared with those subjects of younger age group [34 years
and below] after adjusting for gender and place of resi-
dence. For obesity, we found an RPR of 8.75 [95%
CI:4.00–19.14] in subjects of 65 year and older compared
to the younger subjects.
The overall overweight and obesity prevalences for men
were 50.4% [95% CI:46.5–54.2] and 23.8% [95%
CI:20.6–27.3], and 34.9% [95% CI:32.5–37.5] and
26.8% [95% CI:24.6–29.2] for women. By extrapolating
to the adult population of Castellón, the estimated over-
weight and obesity prevalences for men were 46.8% [95%
CI:46.6–47.1] and 16.0% [95% CI:15.8–16.2], and
29.3% [95% CI:29.1–29.6] and 17.4% [95% CI:17.3–
17.6] for women. Men of all ages tended to have higher
prevalence of overweight than women. The prevalence of
obesity tended to be higher in women after age 45 years
and the difference was significantly higher in the oldest
age group [Table 1].
After adjusting for gender and age, we observed a high
overweight prevalence among the subjects living in a rural
area [p-value < 0.001] with an RPR of 1.57 [95% CI:1.19–
2.07] compared with those living in an urban area. For
obesity, the prevalence was somewhat higher for subjects
living in a rural area than for those living in an urban area,
although no statistically significant differences were
found [RPR of 1.31, 95% CI:0.96–1.80] [Table 3].
Table 2 shows that the undiagnosed HT prevalence
increased with age from 0.8% in the 34 year-old and
younger age group and to 13.1% by age 55–64 years. The
undiagnosed DM prevalence increased with age from
1.6% in the 34 year-old and younger age group to 20.9%
in the 65 year-old and older age group.
Table 2: Age and gender stratified undiagnosed hypertension and diabetes mellitus prevalences among 2062 adult residents of 
Castellón.
Hypertension Diabetes
Men Women Total Men Women Total
Age Group No
% (95%CI)
No
% (95%CI)
No
% (95%CI)
No
% (95%CI)
No
% (95%CI)
No
% (95%CI)
≤ 34 0
-
1
1.2 (0.1–5.6)
1
0.8 (0.1–3.9)
0
-
2
2.3 (0.4–7.5)
2
1.6 (0.3–5.2)
35–44 7
7.9 (3.5–15.1)
9
2.9 (1.4–5.3)
16
4.0 (2.4–6.4)
3
3.4 (0.9–9.0)
10
3.2 (1.7–5.7)
13
3.3 (1.8–5.4)
45–54 14
10.7 (6.3–17.0)
26
7.8 (5.3–11.0)
40
8.6 (6.3–11.4)
14
10.8 (6.3–17.0)
27
8.0 (5.5–11.4)
41
8.8 (6.5–11.7)
55–64 21
15.5 (10.2–22.4)
33
11.9 (8.5–16.2)
54
13.1 (10.1–16.7)
29
21.5 (15.2–29.0)
35
12.7 (9.1–17.0)
64
15.6 (12.3–19.3)
≥ 65 30
11.9 (8.3–16.3)
45
10.8 (8.1–14.1)
75
11.2 (9.0–17.8)
60
23.8 (18.9–29.4)
80
19.2 (15.7–23.2)
140
20.9 (18.0–24.2)
Total 72
11.2 (8.9–13.9)
114
8.0 (6.7–9.6)
186
9.0 (7.8–10.4)
106
16.5 (13.7–19.6)
154
10.8 (9.3–12.6)
260
12.6 (11.2–14.1)
Age and gender-adjusted† % 
(95%CI)
6.0 (5.8–6.1) 5.1 (4.9–5.2) 5.5 (5.4–5.6) 7.3 (7.2–7.5) 7.2 (7.1–7.3) 7.3 (7.2–7.4)
Hypertension: Subjects with systolic pressure > 140 mmHg and diastolic pressure > 90 mmHg
Diabetes: Subjects with venous glycaemia before breakfast > 126 g/dl
No = Number of adults with hypertension or diabetes
† Adjusted for the age and gender distribution of the population of CastellónBMC Research Notes 2009, 2:151 http://www.biomedcentral.com/1756-0500/2/151
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Table 3: Overweight and obesity prevalences and adjusted effects of potential risk factors in adults.
Overweight Obesity
Risk factor Prevalence
(%)
RPR 95%CI P-value Prevalence
(%)
RPR 95%CI P-value
Age
≤ 34 27.4 1(ref.) - 5.7 1(ref.) -
35–44 29.9 1.40 0.87–2.26 14.7 2.89 1.28–6.54
45–54 44.2 4.51 2.76–7.39 <0.001 21.5 4.55 2.05–10.10 <0.001
55–64 42.6 3.29 2.06–5.24 34.8 8.89 4.02–19.65
≥ 65 43.4 4.42 2.78–7.01 33.9 8.75 4.00–19.14
Gender
Women† 34.9 1(ref.) - 26.8 1(ref.) -
Men 50.4 2.06 1.62–2.63 <0.001 23.8 1.10 0.82–1.47 NS
Area
Urban† 38.3 1(ref.) - 26.2 1(ref.) -
Rural 46.6 1.57 1.19–2.07 <0.001 27.8 1.31 0.96–1.80 NS
Overweight: Subjects with BMI = 25.0–29.9 Kg/m2
Obesity: Subjects with BMI ≥ 30.0 Kg/m2
RPR: Relative Prevalence Ratio adjusted for age, gender and place of residence
† Referent group
P-value based on Pearson's chi-square test
NS = Non-Significant
Table 4: Undiagnosed hypertension and diabetes mellitus prevalences and adjusted effects of overweight and obesity on adults.
Hypertension Diabetes
Risk factor Prevalence
(%)
RPR 95%CI P-value Prevalence
(%)
RPR 95%CI P-value
Normal-weight† 4.2 - - 7.8 - -
Overweight 10.6 2.00 1.21–3.32 0.007 9.8 0.90 0.61–1.33 NS
Obese 16.9 1.91 1.48–2.46 <0.001 22.4 1.50 1.25–1.81 <0.001
Hypertension: Subjects with systolic pressure > 140 mmHg and diastolic pressure > 90 mmHg
Diabetes: Subjects with venous gycaemia before breakfast > 126 g/dl
Normal-weight: Subjects with BMI < 25 Kg/m2
Overweight: Subjects with BMI = 25–29.9 Kg/m2
Obese: Subjects with BMI ≥ 30 Kg/m2
RPR: Relative Prevalence Ratio adjusted for age, gender and place of residence
† Referent group
P-value based on Pearson's chi-square test
NS = Non-SignificantBMC Research Notes 2009, 2:151 http://www.biomedcentral.com/1756-0500/2/151
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There was a tendency in all age groups for more undiag-
nosed HT and DM in men compared to women.
The relationship between overweight/obesity and 
undiagnosed HT/DM
As shown in Table 4, the HT prevalence among over-
weight and obese participants was 10.6% and 16.9%,
respectively. Compared to normal-weight adults, over-
weight subjects with HT had an RPR of 2.00 [95%
CI:1.21–3.32], while those with obesity and HT had an
RPR of 1.91 [95% CI:1.48–2.46]; both had been adjusted
for age, gender and place of residence. Finally, the DM
prevalence among overweight and obese participants was
9.8% and 22.4%, respectively. Compared to normal-
weight adults, those who had a combination of obesity
and DM showed an RPR of 1.50 [95% CI:1.25–1.81].
Discussion
We observed a high prevalence of overweight and obesity
in a Mediterranean region, and this result coincides with
other studies [4]. The obesity prevalence found in both
men [23.8%] and women [26.8%] is among the highest of
Europe [4.0–28.3% in men and 6.2–36.5% in women]
[4]. The total prevalence even exceeds that of other non-
European countries like the United States [20.3%] [6].
Studies done on adults in other Mediterranean areas in
Spain detected similar obesity prevalences [18]. These
prevalences are higher than those described for the whole
of Spain [15.5%] [3]. Therefore our results demonstrate
that a geographically distributed obesity prevalence exists
in Spain, which is higher in the Southeast [5,6]. Our study
also determines the association of these overweight and
obesity prevalences with undiagnosed DM and HT, which
is new and different from these earlier published Spanish
data.
Both overweight and obesity appears to increase with age.
This may be due to people of this age living a more seden-
tary lifestyle. Besides, a series of physiological alterations
take place with age which increase body weight [5].
The overweight prevalence generally tended to be higher
in men than in women. However, the obesity prevalence
tended to be higher in women than in men. This indicates
that obesity prevention measures must address men and
women equally.
Like other Spanish studies [19], higher overweight and
obesity prevalences were noted for the rural population,
although only the overweight prevalence was statistically
significant. In the past, the overweight prevalence was tra-
ditionally higher in urban areas. However, the opposite
trend applies nowadays [19]. This could be because sub-
jects living in rural areas have poorer access to health care
and they practice medical selfcare less.
These high overweight and obesity prevalences could be
responsible for a possible epidemic of associated adverse
effects [1,3]. Subjects with a higher BMI are at greater risk
of suffering cardiovascular diseases [20-22]. An associa-
tion between severe obesity and a dysfunction of the left
ventricle was first observed in the mid 20's [20]. Later,
clinical and necroscopic studies confirmed that cardiomy-
opathies were associated with obesity [22,23]. Echo-cardi-
ography studies, catheterisation and necroscopic
examination have revealed a relationship between obesity
and certain alterations to both the heart structure and the
systolic function in moderate obesity [23]. We detected
that the undiagnosed HT prevalence, was statistically and
significantly higher in overweight than in normal-weight
subjects, and was even higher in obese subjects. Therefore,
anyone who is somewhat over their ideal weight could
benefit from a moderate weight loss in order to be at less
risk of HT [24].
We also noted that the undiagnosed DM prevalence was
statistically and significantly higher in obese subjects than
in normal-weight subjects. BMI is an indicator of obesity
and would be a possible indicator of the risk of DM
[25,26].
We also observed that the prevalence of this pathology
increased significantly with age, as other authors discov-
ered [27]. Therefore, the detection of an abnormal glucose
metabolism in elderly obese subjects would help control
the disease. Taking healthy lifestyle habit measures has
proved more effective than pharmacological treatments to
prevent the onset of DM [28]. Early prevention pro-
grammes that centre on changing lifestyle habits are very
important.
This study is not without its limitations. The main limita-
tion is the sample's lack of representativeness produced by
the fact that the response rate was much more elevated in
women than in men. Also, for those cases in which hyper-
glycaemia was absent, a diagnosis of DM was not con-
firmed with a second test. The Oral Glucose Tolerance Test
was not done; therefore the prevalence of undiagnosed
DM could be underestimated.
Conclusion
This study provides strong evidence for overweight and
obesity prevalences in the general population. Besides, it
demonstrates the important role that obesity plays as a
main modifiable risk factor in the development of comor-
bidities like HT and DM and its use in early diagnoses.
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